drugset / Trial / NCT05292495
A Trial of HR17031 Injection With Renal Insufficiency
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study used a single-dose, open design to compare the pharmacokinetics of subjects with mild, moderate and severe renal insufficiency and end-stage renal disease and subjects with normal renal function.
Timeline
- Start
- 2022-10-12
- Primary completion
- 2024-04-10
- Completion
- 2024-04-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HR17031 | Unknown | — | Subcutaneous |
Indications
No indication recorded.